Furthermore, it is notable that PD-1 expression is a component in 6 of the 7 checkpoint combinations that are increased on NK cells in patients, implying a potentially important central role for PD-1 in the checkpoint regulation of NK cells in CLL. Here, PDCD1 is linked to B-cell chronic lymphocytic leukemia.